A $10,000 Investment in Goldman Sachs in 2016 Is Now Worth More Than $60,000. Its Record Revenue This Year Says the Run Isn't Over.

Goldman Sachs reported record revenue of $56.2 billion for the first nine months, up 25% year over year, and earnings of $17.5 billion, up 40%. Q3 revenue rose 23% to $18.7 billion and EPS increased 39% to $17.01; investment-banking fees grew 40% to $9.5 billion and equities trading income rose 57% to $19.2 billion. The bank raised its quarterly dividend 11% to $5 per share, while shares were up about 2% year to date and traded at 12 times earnings.

Analysis

The key risk is earnings quality, not whether the reported quarter was strong. Investment-banking fees and equities trading are highly sensitive to deal completions, issuance windows, client activity and market conditions; annualizing peak activity can make a 12x earnings multiple look cheaper than it is. A downturn could compress both earnings and the multiple. Asset-management inflows provide a useful counterweight, but flows alone do not establish durable fee growth: mix, fee rates, and market-driven asset values matter.

Near term (days), the stock’s muted year-to-date return despite strong results could support a catch-up move, but the article provides no evidence on positioning, estimates or valuation basis to establish a catalyst or mispricing. Over 1–3 months, watch forward guidance, deal pipeline conversion, trading revenue and expense growth. Over 6–18 months, sustained fee-based growth would improve earnings resilience; a renewed deal slowdown or weaker markets would expose the cyclicality. Competitors such as Morgan Stanley and JPMorgan Chase may also benefit from stronger capital-markets activity, limiting the durability of any GS-specific premium.

Contrarian view: the market may be discounting peak-cycle earnings rather than overlooking a bargain. The dividend increase is not proof of a permanently higher payout path; capital requirements and earnings volatility constrain distributions. No strong outright trade follows from this article alone.

Key Decisions for Investors

• No immediate directional position on this evidence alone. Treat the low stated P/E as a screening signal, not a buy trigger; verify whether it is trailing or forward and compare normalized earnings with peers before adding.
• Watch for the next 1–3 months: favor a staged long in GS only if management’s outlook and subsequent results show investment-banking activity converting into fees while asset-management flows translate into recurring fee revenue. Define thesis failure as falling capital-markets revenue alongside asset outflows or materially faster expense growth.
• For a relative-value expression, monitor GS against Morgan Stanley and JPMorgan Chase rather than initiating a pair now. Consider long GS only if capital-markets momentum is demonstrably stronger without a valuation premium unsupported by normalized earnings; reverse that view if activity weakens or GS underperforms peers.
• Do not extrapolate the dividend growth rate. Reassess after capital-return guidance and regulatory-capital disclosures; a payout restraint or deterioration in earnings would invalidate the income-support thesis.